Vice President, Medical Affairs (TechBio)

Location: Fully remote within the United States, with occasional travel for collaboration, team events, customer meetings, and other business needs.

Annual base salary: $326,300–$408,400 for Salt Lake City and other U.S. locations; $358,930–$449,240 for New York City, Boston, and the San Francisco Bay Area. Additional annual bonus, equity compensation, and benefits are available.

Company

hirify.global is a clinical-stage TechBio company using biology, chemistry, automation, data science, and AI to develop medicines and industrialize drug discovery.

What you will do

• Develop integrated Medical Affairs strategies for clinical-stage assets, including scientific narratives, evidence gaps, stakeholder engagement, publications, medical education, advisory boards, field medical planning, and launch readiness.
• Partner with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development.
• Build evidence-generation plans covering real-world evidence, HEOR, epidemiology, natural history, treatment patterns, burden of disease, and outcomes-focused studies.
• Lead scientific engagement with healthcare professionals, investigators, patient communities, payers, health systems, scientific leaders, professional societies, and other external stakeholders.
• Direct congress strategy, medical communications, publication planning, advisory boards, medical information, scientific training, and medical education.
• Design and build a scalable Medical Affairs organization with governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes.

Requirements

• Advanced clinical or scientific degree required; MD, DO, PharmD, PhD, or equivalent preferred.
• 15+ years of biotechnology or pharmaceutical industry experience, including significant Medical Affairs leadership experience.
• Experience leading Medical Affairs strategy for clinical-stage or launch-stage assets, ideally in oncology, rare disease, immunology, or other specialty therapeutic areas.
• Proven experience with integrated evidence planning, drug development from early clinical development through launch readiness, and lifecycle planning.
• Demonstrated success engaging KOLs, investigators, patient advocacy organizations, professional societies, payers, HTA stakeholders, and external experts through compliant scientific exchange.
• Strong knowledge of compliance expectations for scientific exchange, medical review, publications, advisory boards, and healthcare professional interactions in the U.S. and globally.

Culture & Benefits

• Fully remote U.S. work arrangement with occasional business travel.
• Annual bonus, equity compensation, and comprehensive benefits package.
• Values-driven environment emphasizing integrity, accountability, direct engagement, rapid learning, urgency, and cross-functional collaboration.
• Opportunity to work with biology, chemistry, clinical development, data science, and AI platforms addressing significant unmet medical needs.